Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Labeled, Multicentre, Randomized Phase II Trial of Combination Gemcitabine and Carboplatin Chemotherapy in Patients With Metastatic or Recurrent Nasopharyngeal Carcinoma

NCT00697905 is registered in ClinicalTrials.gov with Ministry of Health, Malaysia as lead sponsor.

NCT NCT00697905
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00697905 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Labeled, Multicentre, Randomized Phase II Trial of Combination Gemcitabine and Carboplatin Chemotherapy in Patients With Metastatic or Recurrent Nasopharyngeal Carcinoma
Lead sponsor
Ministry of Health, Malaysia
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2008
Completion date
May 31, 2011
Enrollment
18 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

nasopharyngeal carcinoma